Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Maria Collado

Psychiatry Juncos, PR Medical Doctor

NPI 1073817383 CMS profile 185598

Calle Munoz Rivera #49, Juncos, PR 00777

Open in the dashboard

General payments

$23,077

502 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Maria Collado of Juncos, PR is reported in the CMS Open Payments database as having received $23,077 across 502 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,572 71
2024 General $3,380 68
2023 General $1,903 104
2022 General $8,919 100
2021 General $1,153 65
2020 General $1,226 54
2019 General $924 40

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Maria Collado
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Maria Collado were reported at $5,572. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Maria Collado Psychiatry median Middle half National median
2019 $924 $184 $59–$605 $163
2020 $1,226 $119 $36–$372 $114
2021 $1,153 $143 $43–$576 $132
2022 $8,919 $153 $50–$590 $149
2023 $1,903 $170 $56–$651 $160
2024 $3,380 $179 $57–$673 $164
2025 $5,572 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alkermes, Inc. $8,827 93 payments
  2. E.R. Squibb & Sons, L.L.C. $6,089 22 payments
  3. Otsuka America Pharmaceutical, Inc. $1,705 93 payments
  4. Janssen Pharmaceuticals, Inc $1,398 66 payments
  5. Indivior Inc. $1,162 63 payments
  6. Teva Pharmaceuticals USA, Inc. $949 43 payments
  7. ITI, Inc. $667 29 payments
  8. Neurocrine Biosciences, Inc. $521 11 payments
  9. AbbVie, Inc. $481 26 payments
  10. Almatica Pharma LLC $272 13 payments
  11. Other $1,007 43 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $11,270 4 payments
  2. Food and Beverage $10,438 488 payments
  3. Travel and Lodging $1,302 3 payments
  4. Education $68 7 payments
Products named General payments · program years 2019–2025
  1. LYBALVI Cns $8,121 65 payments
  2. LYBALVI Cns $7,469 24 payments
  3. LYBALVI Cns $7,270 11 payments
  4. LYBALVI Cns $7,270 11 payments
  5. ARISTADA Cns $1,465 77 payments
  6. ARISTADA Cns $1,465 77 payments
  7. ARISTADA Cns $1,243 63 payments
  8. ARISTADA Cns $1,243 63 payments
  9. INVEGA SUSTENNA $1,204 61 payments
  10. PERSERIS $1,162 63 payments
  11. Other $8,621 416 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

502 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Puerto Rico

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record